Ubiquitin-mediated regulation of CD86 protein expression by the ubiquitin ligase membrane-associated RING-CH-1 (MARCH1)
- PMID: 21896490
- PMCID: PMC3199464
- DOI: 10.1074/jbc.M110.204040
Ubiquitin-mediated regulation of CD86 protein expression by the ubiquitin ligase membrane-associated RING-CH-1 (MARCH1)
Abstract
The activation of naïve T cells requires antigen presentation by dendritic cells (DCs), and the process of antigen presentation is regulated over the course of DC maturation. One key aspect of this regulation is the cell surface up-regulation upon DC maturation of peptide·MHC-II complexes and the costimulatory molecule CD86. It is now clear that these critical induction events involve changes in ubiquitin-dependent trafficking of MHC-II and CD86 by the E3 ligase membrane-associated RING-CH-1 (MARCH1). Although ubiquitin-dependent trafficking of MHC-II has been well characterized, much less is known regarding the post-transcriptional regulation of CD86 expression. Here, we examined the physical and functional interaction between CD86 and MARCH1. We observed that CD86 is rapidly endocytosed in the presence of MARCH1 followed by lysosome-dependent degradation. Furthermore, we found that the association between CD86 and MARCH1 was conferred primarily by the transmembrane domains of the respective proteins. In contrast to MHC-II, which has a single, conserved ubiquitin acceptor site in the cytosolic domain, we found that multiple lysine residues in the cytosolic tail of CD86 could support ubiquitination consistent with the relative lack of sequence conservation across species within the CD86 cytosolic domain. These findings suggest that MARCH1 recruits multiple substrates via transmembrane domain-mediated interactions to permit substrate ubiquitination in the face of diverse cytosolic domain sequences.
Figures






Similar articles
-
CD83 increases MHC II and CD86 on dendritic cells by opposing IL-10-driven MARCH1-mediated ubiquitination and degradation.J Exp Med. 2011 Jan 17;208(1):149-65. doi: 10.1084/jem.20092203. Epub 2011 Jan 10. J Exp Med. 2011. PMID: 21220452 Free PMC article.
-
Ubiquitination of CD86 is a key mechanism in regulating antigen presentation by dendritic cells.J Immunol. 2011 Sep 15;187(6):2966-73. doi: 10.4049/jimmunol.1101643. Epub 2011 Aug 17. J Immunol. 2011. PMID: 21849678 Free PMC article.
-
Discrete domains of MARCH1 mediate its localization, functional interactions, and posttranscriptional control of expression.J Immunol. 2009 Nov 15;183(10):6500-12. doi: 10.4049/jimmunol.0901521. Epub 2009 Oct 30. J Immunol. 2009. PMID: 19880452 Free PMC article.
-
MARCH ligases in immunity.Curr Opin Immunol. 2019 Jun;58:38-43. doi: 10.1016/j.coi.2019.03.001. Epub 2019 May 4. Curr Opin Immunol. 2019. PMID: 31063934 Review.
-
RING domain E3 ubiquitin ligases.Annu Rev Biochem. 2009;78:399-434. doi: 10.1146/annurev.biochem.78.101807.093809. Annu Rev Biochem. 2009. PMID: 19489725 Review.
Cited by
-
The ins and outs of MHC class II-mediated antigen processing and presentation.Nat Rev Immunol. 2015 Apr;15(4):203-16. doi: 10.1038/nri3818. Epub 2015 Feb 27. Nat Rev Immunol. 2015. PMID: 25720354 Free PMC article. Review.
-
Ubiquitination by the membrane-associated RING-CH-8 (MARCH-8) ligase controls steady-state cell surface expression of tumor necrosis factor-related apoptosis inducing ligand (TRAIL) receptor 1.J Biol Chem. 2013 Mar 1;288(9):6617-28. doi: 10.1074/jbc.M112.448209. Epub 2013 Jan 8. J Biol Chem. 2013. PMID: 23300075 Free PMC article.
-
The Role of the Transmembrane RING Finger Proteins in Cellular and Organelle Function.Membranes (Basel). 2011 Dec 9;1(4):354-93. doi: 10.3390/membranes1040354. Membranes (Basel). 2011. PMID: 24957874 Free PMC article.
-
Human and viral membrane-associated E3 ubiquitin ligases MARCH1 and MIR2 recognize different features of CD86 to downregulate surface expression.J Biol Chem. 2021 Jul;297(1):100900. doi: 10.1016/j.jbc.2021.100900. Epub 2021 Jun 19. J Biol Chem. 2021. PMID: 34157285 Free PMC article.
-
Dendritic Cell-Specific Role for Pellino2 as a Mediator of TLR9 Signaling Pathway.J Immunol. 2021 Nov 1;207(9):2325-2336. doi: 10.4049/jimmunol.2100236. Epub 2021 Sep 29. J Immunol. 2021. PMID: 34588221 Free PMC article.
References
-
- Heath W. R., Carbone F. R. (2009) Nat. Immunol. 10, 1237–1244 - PubMed
-
- Ueno H., Klechevsky E., Morita R., Aspord C., Cao T., Matsui T., Di Pucchio T., Connolly J., Fay J. W., Pascual V., Palucka A. K., Banchereau J. (2007) Immunol. Rev. 219, 118–142 - PubMed
-
- Banchereau J., Steinman R. M. (1998) Nature 392, 245–252 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials